Extended-release carbamazepine capsules: In bipolar I disorder

CNS Drugs

Volumn 19, Issue 8, 2005, Pages 709-716

  Harrison, Tracy Swainston ^a   Keating, Gillian M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIMALARIAL AGENT; CARBAMAZEPINE; CHLOROQUINE; LITHIUM; ANTICONVULSIVE AGENT;

AGRANULOCYTOSIS; APLASTIC ANEMIA; AREA UNDER THE CURVE; ASTHENIA; ATAXIA; BIPOLAR I DISORDER; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG RELEASE; DYSPEPSIA; EPILEPSY; ERYTHEMA; FEVER; HUMAN; LEUKOPENIA; NAUSEA; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; SOMNOLENCE; SPEECH DISORDER; TRIGEMINUS NEURALGIA; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA; BIPOLAR DISORDER; DELAYED RELEASE FORMULATION;

ANTICONVULSANTS; BIPOLAR DISORDER; CARBAMAZEPINE; DELAYED-ACTION PREPARATIONS; HUMANS;

EID: 24144491361     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200519080-00006     Document Type: Review

References (20)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002 Apr; 159 (4 Suppl.): 1-50
2. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry 2000; 61 Suppl. 13: 38-41
3. Belmaker RH. Bipolar disorder. N Engl J Med 2004; 351: 476-86
4. Collins RJ, Garnett WR. Extended release formulations of anticonvulsant medications: clinical pharmacokinetics and therapeutic advantages. CNS Drugs 2000; 14 (3): 203-12
5. Innes, C. SPD 417 effective for manic and mixed symptoms of bipolar disorder. Inpharma 2004 Jun 19; 1442: 7-8
6. Weisler RH, Kalali AH, Ketter TA, et al. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004 Apr; 65 (4): 478-84
7. Data on file. Shire Pharmaceuticals US, 2005
8. Shire US Inc. Carbatrol® (carbamazepine extended-release capsules) prescribing information 2003 [online]. Available from URL: http://www.carbatrol. com [Accessed 2005 May 2]
9. Shire US Inc. Equetro™ (carbamazepine) extended-release capsules prescribing information 2004 [online]. Available from URL: http://www.equetro. com [Accessed 2005 May 2]
10. Gould TD, Quiroz JA, Singh J, et al. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 2004; 9: 734-55
11. Bertilsson L, Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide: an update. Clin Pharmacokinet 1986; 11: 177-98
12. Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic drug interactions with carbamazepine: an update. Clin Pharmacokinet 1996; 31 (3): 198-214
13. Garnett WR, Levy B, McLean AM, et al. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy. Epilepsia 1998 Mar; 39: 274-9
14. McLean A, Browne S, Zhang Y, et al. The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation. J Clin Pharmacol 2001; 41: 183-6
15. Weisler RH, Keck Jr PE, Swann AC, et al. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2005 Mar; 66 (3): 323-30
16. Ketter TA, Kalali AH, Weisler RH, et al. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004 May; 65 (5): 668-73
17. Weisler RH, Hirschfeld R, Cutler AJ, et al. Efficacy of extended-release carbamazepine in bipolar disorder: results of 2 pooled clinical trials [poster no. 24]. 17th Annual U.S. Psychiatric Mental Health Congress; 2004 Nov 18-21; San Diego, (CA)
18. American Heart Association. Cholesterol ratio: AHA recommendation [online]. Available from URL: http://www.americanheart.org [Accessed 2005 Jun 9]
19. Ketter A. Extended-release carbamazepine capsules as monotherapy for bipolar disorder: effect on plasma cholesterol levels and body weight [poster]. 45th Annual Meeting of the New Clinical Drug Evaluation Unit; 2005 Jun 6-9; Boca Raton (FL)
20. Shire Pharmaceuticals Group plc. Shire receives US FDA approval of EQUETRO™ for bipolar disorder [online]. Available from URL: http://www.shire.com [Accessed 2004 Dec 20]